Monthly Archives: November 2013

Farmers Will Respond Sustainably to Increased Demand for Food and Fuel

admin-ajax

News of this year’s corn crop should put to rest the debate over whether the nation’s corn crop is redirected for fuel use at the expense of feed for livestock. With the release of its 2013 corn crop report, the USDA has estimated that this year’s corn harvest will hit a new record of 13.99 billion bushels, which is 7% larger than the previous year. Additionally, corn prices are projected at $4.10-$4.90 per bushel, the Read More >

Food And Agriculture  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Patents Improve Public Health: Progressive Economy Reviews TRIPS at 20 Years

flags with blue sky

Progressive Economy released a research paper examining the effect of TRIPS (Trade-Related Aspects of Intellectual Property) on global health. Here are their findings quoted from their press release: “1. Since the TRIPS agreement went into effect on New Year’s Day 1995, research and development spending has risen significantly worldwide (relative to the size of GDP). For OECD members, the rise is from 2.1 percent to 2.4 percent of GDP, or in practice an additional $220 Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

A Manhattan Project for Alzheimer’s Disease

James Greenwood STILL 5_EDIT

Earlier this month, at the Alzheimer’s Disease Summit in New York City, BIO‘s President & CEO Jim Greenwood highlighted the need for our nation to think bigger about how we approach Alzheimer’s Disease. Greenwood called for a “Manhattan Project” to rally the country around addressing this growing health challenge.  He also noted that addressing Alzheimer’s Disease is the type of issue that could bring together elected officials on both sides of the aisle. As part Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , ,

Sequester Threatens FDA Mission

FDA115x76

One aspect of sequestration isn’t doing anything to reduce the deficit, but could be delaying patient access to new drugs and medical devices, according to the FDA’s Janet Woodcock at a House subcommittee hearing on Friday. The FDA is being denied access to some of the user fees paid by the drug and device industries, which are intended to fund FDA’s review and oversight programs and ensure timely patient access to new and effective treatments. Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

New Cancer Treatments Seek to Give the Immune System Superpowers

Wendy Selig 2013

Melanoma is scary. It is aggressive, spreads quickly to far-away organs with the stealth and cunning of the most adept villain, and it is increasingly striking young people-it is now the most common form of cancer diagnosed in women 25-29. But the “good guys” are fighting back with increasing success. As the CEO of the Melanoma Research Alliance (MRA), a patient-focused, science-based organization dedicated to fighting this deadly skin cancer, I see signs every day Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,